Item 5.02. DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.
(e) Compensatory Arrangements of Certain Officers.
Executive Bonus Plan 2022
On
The bonuses payable to
(i) Up to 50% of the Bonus Target for the vaccine development program's Phase I clinical trial;
(ii) Up to 20% of the Bonus Target for the Company's raising of additional capital;
(iii) Up to 7.5% of the Bonus Target for lantibiotic research and development planning;
(iv) Up to 7.5% of the Bonus Target for the Company's share performance;
(v) Up to 7.5% of the Bonus Target for strategic planning initiatives; and
(vi) Up to 7.5% of the Bonus Target related to ensuring legal and regulatory compliance across the business.
The bonuses payable to
(i) Up to 40% of the Bonus Target for financial performance objectives including the Company's raising of additional capital, budgeting and financial planning;
(ii) Up to 20% of the Bonus Target for strategic planning initiatives;
(iii) Up to 20% of the Bonus Target for the Company's share performance; and
(iv) Up to 20% of the Bonus Target for external corporate communications, physical location management, and personnel development.
The bonuses payable to
(i) Up to 50% of the Bonus Target for lantibiotic research and development and regulatory filings;
(ii) Up to 20% of the Bonus Target for the vaccine development program, including pending toxicology study;
(iii) Up to 15% of the Bonus Target for strategic initiatives regarding the Company's antivirals program research and development; and
(iv) Up to 15% of the Bonus Target for administrative, management, and regulatory compliance matters.
The executive officers' actual bonuses for fiscal year 2022 may exceed 100% of their 2022 Bonus Target percentage in the event performance exceeds the predetermined goals and/or upon the achievement of other specified goals, including stretch goals.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source